No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs116468173 |
chr11:65927155-65927156 |
Enhancers Weak transcription Strong transcription
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
2 |
rs533198239 |
chr11:65927159-65927160 |
Enhancers Weak transcription Strong transcription
|
Chromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs142801564 |
chr11:65927180-65927181 |
Enhancers Weak transcription Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs34491186 |
chr11:65927191-65927192 |
Enhancers Weak transcription Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs560311180 |
chr11:65927201-65927202 |
Enhancers Weak transcription Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs528853335 |
chr11:65927267-65927268 |
Enhancers Weak transcription Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs550894404 |
chr11:65927339-65927340 |
Enhancers Weak transcription Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs117953016 |
chr11:65927362-65927363 |
Enhancers Weak transcription Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs568881235 |
chr11:65927378-65927379 |
Enhancers Weak transcription Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs531100077 |
chr11:65927514-65927515 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs918299 |
chr11:65927607-65927608 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
12 |
rs191730074 |
chr11:65927649-65927650 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs526200 |
chr11:65927773-65927774 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
14 |
rs553017185 |
chr11:65927793-65927794 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs566636222 |
chr11:65927817-65927818 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs553141472 |
chr11:65927832-65927833 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs535795854 |
chr11:65927855-65927856 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs555476365 |
chr11:65927937-65927938 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs575636267 |
chr11:65927956-65927957 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs17147376 |
chr11:65927967-65927968 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
21 |
rs147411747 |
chr11:65927979-65927980 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs693382 |
chr11:65928018-65928019 |
Weak transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
23 |
rs540436619 |
chr11:65928052-65928053 |
Weak transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs138132318 |
chr11:65928054-65928055 |
Weak transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs573775791 |
chr11:65928108-65928109 |
Weak transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs58145434 |
chr11:65928151-65928152 |
Weak transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs801737 |
chr11:65928193-65928194 |
Weak transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
28 |
rs143694142 |
chr11:65928245-65928246 |
Weak transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs538778533 |
chr11:65928258-65928259 |
Weak transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs531364236 |
chr11:65928317-65928318 |
Weak transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs10488727 |
chr11:65928342-65928343 |
Weak transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
32 |
rs564453897 |
chr11:65928343-65928344 |
Weak transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs183259764 |
chr11:65928355-65928356 |
Weak transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs546796514 |
chr11:65928423-65928424 |
Weak transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs801736 |
chr11:65928430-65928431 |
Weak transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
36 |
rs374835376 |
chr11:65928440-65928441 |
Weak transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs535570861 |
chr11:65928479-65928480 |
Weak transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs188136376 |
chr11:65928492-65928493 |
Weak transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs113698380 |
chr11:65928527-65928528 |
Weak transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs113275544 |
chr11:65928559-65928560 |
Weak transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs139438079 |
chr11:65928563-65928564 |
Weak transcription Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs77768751 |
chr11:65928609-65928610 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs375532494 |
chr11:65928654-65928655 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs538260286 |
chr11:65928659-65928660 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs369972326 |
chr11:65928682-65928683 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs558049971 |
chr11:65928737-65928738 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs578001144 |
chr11:65928772-65928773 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs575584361 |
chr11:65928779-65928780 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs192931348 |
chr11:65928822-65928823 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs573811273 |
chr11:65928853-65928854 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|